Navigation Links
VacChina 2011 - Bridging the China Vaccine Industry with the World Class Biotechnologies
Date:8/18/2011

SHANGHAI, Aug. 18, 2011 /PRNewswire-Asia/ -- VacChina 2011 -- China's largest vaccine meeting -- welcomes world class biotechs and pharmas to discuss the opportunities of development of novel vaccine R&D and manufacturing technologies in China.

The World Health Organization (WHO) announced on March 1, 2011, that the national regulatory authority of China -- the State Food and Drug Administration (SFDA), along with affiliated institutions -- now meets WHO indicators for a functional vaccine regulatory system. This means that Chinese-made vaccines are now eligible to apply for WHO pre-qualification. On the same day as this WHO announcement, the China SFDA also adopted a new Good Manufacturing Practice code. The new code puts in place stricter requirements for vaccine production, in line with international standards, in order to ensure quality.

The announcement will motivate domestic manufacturers to strengthen vaccine development partnerships with international organizations at broader and more strategic levels. More government funding will also pour into companies working toward the goal of WHO pre-qualification. Furthermore, a new interest in vaccine technology will encourage Chinese scientists who are now working overseas to return to the country in order to leverage this opportunity.

Supported by BayHelix and hosted by Global Leaders Institute, world vaccine industry leaders will convene at VacChina 2011 on Nov 29 and 30 in Shanghai. The two-day executive summit will explore the major partnering opportunities in the vaccine industry in China. The goal of the summit is to bridge the China vaccine industry with the world class biotechnologies in terms of vaccine R&D and production.

Key issues to be addressed:

  • The requirements or the process of WHO pre-qualification, UNICEF procurement programs, or GAVI's working mechanisms
  • How to align China SFDA's regulatory pathways and domestic clinical trials with international standards and requirements
  • What do new Chinese Good Manufacturing Practice (GMP) standards and WHO approval for China's vaccine regulatory system mean for China's vaccine industry? Now that Chinese vaccine manufacturers can apply for WHO prequalification, will China take on a bigger role as a global vaccine supplier? Should we expect China to take a larger role developing novel vaccines?
  • What kind of assistance do SFDA, CDC and Chinese manufacturers need from international partners (WHO, UNICEF, PATH, etc) to improve and meet international standards? How will China respond to international concerns about quality and safety of Chinese vaccines?
  • Novel approaches to cell culture to accelerate development and quality control
  • How to improve cost and time to the clinic and ensure product quality through downstream processing
  • Strategies to accelerate vaccine development process with the latest expression and characterization technologies

For more information, please visit vac.globaleaders.com or contact:

Daniel Chen
Tel: +86-21-3251-6046 or email: daniel.chen@globaleaders.com


'/>"/>
SOURCE Global Leaders Institute
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Vaccine Leaders All Over the World Talking About China Vaccine Opportunities at VacChina 2010 -- the No.1 China Focused Vaccine Partnering Forum
2. VacChina 2010 - A Premium Event to Define the Vaccine Industry in Asia
3. TRIA Beauty Leading the Charge in Bridging Gap Between Science and Skin Health
4. PAREXEL Achieves 100th Asian Ethnobridging Study Milestone
5. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
6. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
7. China Contract Research Organization (CRO) Industry Report, 2010-2011
8. Abbott Expanding Manufacturing Capacity in China to Meet Demands of Fast-Growing Nutrition Market
9. China Nuvo Solar Target Acquisition SurgLine Updates OptiMedical Corp.s Sales Forecast in Excess of $10,000,000
10. China Medical Technologies Reports First Fiscal Quarter Financial Results
11. Chairman of Global Guide to COPD Diagnosis Committee Visited West China Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... One of Australia,s successful biotechnology ... a new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ... to list on the ASX. Noxopharm is a clinic-ready ... a Phase 1 clinical study later this year. ... the biggest problems facing cancer patients - the ability of cancers ...
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ... Antitrust Improvements Act of 1976, as amended ("HSR"), with ... ("Celator"; Nasdaq: CPXX ) expired effective June ... As previously announced on May 31, 2016, Jazz ... under which Jazz Pharmaceuticals has commenced a tender offer ...
(Date:6/26/2016)...  VMS Rehab Systems, Inc. ( www.vmsrehabsystemsinc.com ) reported ... required to build a strong and stable market for ... on the OTC Markets-pink current trading platform. ... are seeing an anomaly in market trading activities that ... the Company, but shareholders and market players as well. ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media ... give their videos a whole new perspective by using the title layers in ... Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library on June ... , brings up a new, often overlooked aspect of head lice: the parasite’s ability to ... is not a common occurrence, but a necessary one in the event that lice have ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
Breaking Medicine News(10 mins):